AYTU vs MDLZ · rev $66.4M vs P/E 30, rev $38.54B
Aytu BioScience Inc (AYTU) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
AYTU currently screens at market cap $24.1M. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the AYTU and MDLZ stock pages for the full models.
Not investment advice.